---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-107941"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:49:01.570155+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Denali Capital Acquisition Corp. extends combination deadline to Jan 11, 2025; deposits $15,064

## Summary
- Deposited $15,063.74 into trust account to extend deadline from Dec 11, 2024 to Jan 11, 2025.
- Extension funded via convertible promissory note from Scilex Holding Company (Nasdaq: SCLX) for up to $180,000.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share into Class A ordinary shares.
- Remaining $104,708.30 principal available for future monthly extensions.

## SEC filing metadata
- accession: 0001213900-24-107941
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024107941/0001213900-24-107941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024107941/ea022443401-8k_denalicap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-107941
- JSON: https://secwatch.observer/filing/0001213900-24-107941.json
- Plain text: https://secwatch.observer/filing/0001213900-24-107941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.